Ilse Houtenbos

Hoofddorp, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Small and Large Extracellular Vesicles in Circulation of Diffuse Large B-Cell Lymphoma Patients Originate From Different Cell Types of the Tumor Microenvironment.

Small and Large Extracellular Vesicles in Circulation of Diffuse Large B-Cell Lymphoma Patients Originate From Different Cell Types of the Tumor Microenvironment.

Journal: Journal of extracellular vesicles

Published: April 02, 2025

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.

Journal: Blood

Published: February 22, 2023

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.

Journal: The Lancet. Haematology

Published: November 12, 2021

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study.

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study.

Journal: European journal of clinical pharmacology

Published: March 11, 2021

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.

Journal: Cancer reports (Hoboken, N.J.)

Published: February 02, 2021

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 21, 2020

Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial.

Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial.

Journal: Internet interventions

Published: September 11, 2020

Guidelines for mono, double and triple antithrombotic therapy.

Guidelines for mono, double and triple antithrombotic therapy.

Journal: Postgraduate medical journal

Published: August 25, 2020

Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.

Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.

Journal: European journal of clinical pharmacology

Published: March 26, 2020

Cost-utility of an eHealth application 'Oncokompas' that supports cancer survivors in self-management: results of a randomised controlled trial.

Cost-utility of an eHealth application 'Oncokompas' that supports cancer survivors in self-management: results of a randomised controlled trial.

Journal: Journal of cancer survivorship : research and practice

Published: March 10, 2020

Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.

Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.

Journal: The Lancet. Oncology

Published: June 26, 2019

Macroscopic hematuria as presenting symptom of celiac disease.

Macroscopic hematuria as presenting symptom of celiac disease.

Journal: The Netherlands journal of medicine

Published: March 22, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026